Select Language
Free Registration

HLA-A*3303 | B2M

Product Inquiry

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
KLT-1101KLT-1101Phase 2 ClinicalKang Litai Pharmaceutical Co LtdSolid tumours; Leukopenia; Thrombocytopenia; Melanoma; Sarcoma, Kaposi
Details
Edodekin alfaRO 247472; YM 01CPhase 2 ClinicalWistar Institute, Valeant, F. Hoffmann-La Roche LtdBreast Neoplasms; Leishmaniasis; Bacterial Infections; Melanoma; Sarcoma, Kaposi; Lymphoma, T-Cell, Cutaneous; Lymphoma, Non-Hodgkin; Lymphoma; Carcinoma, Squamous Cell; Hepatitis C; Asthma; Solid tumours; Hepatitis B; Graft vs Host Disease; Carcinoma, Ovarian Epithelial; Neoplasms; Malaria; Carcinoma, Renal Cell; Abdominal Neoplasms; Squamous Cell Carcinoma of Head and Neck; HIV Infections
Details
GEN-1phIL-12-005/PPC; GEN-1; EGEN-001; IMNN-001Phase 2 ClinicalExpression GeneticsCystadenocarcinoma; Ovarian Neoplasms; Cystadenocarcinoma, Serous; Carcinoma, Ovarian Epithelial; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Endometrioid
Details
RTX-224RTX-224Phase 2 ClinicalRubius Therapeutics IncSkin Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung
Details
SON-1010SON-1010Phase 2 ClinicalSonnet Biotherapeutics IncOvarian Neoplasms; Solid tumours
Details
ASP-9801ASP-9801Phase 1 ClinicalAstellas Pharma IncSolid tumours; Neoplasms; Neoplasm Metastasis
Details
ANK-101ANK101; ANK-101Phase 1 ClinicalAnkyra Therapeutics IncSolid tumours; Soft Tissue Injuries; Skin Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
CLN-617CLN-617Phase 1 ClinicalCullinan OncologySolid tumours
Details
KB-707KB-707; KB707Phase 1 ClinicalKrystal Biotech IncSolid tumours; Skin Melanoma; Carcinoma, Basal Cell; Carcinoma, Renal Cell; Small Cell Lung Carcinoma; Neoplasms; Sarcoma; Osteosarcoma; Colorectal Neoplasms; Carcinoma, Squamous Cell; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Hepatocellular
Details
Encapsulated pancreatic cancer vaccine(Therapyx)PCX-12Phase 1 ClinicalTherapyX IncPancreatic Neoplasms
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
Ustekinumab biosimilar (Samsung Bioepis)SB-17; SB17ApprovedSamsung Bioepis Co LtdPyzchivaEUCrohn Disease; Colitis, UlcerativeSamsung Bioepis Nl Bv2024-04-19Gastrointestinal Diseases; Skin Diseases; Psoriasis; Arthritis, Psoriatic; Rheumatic Diseases; Colitis, Ulcerative; Inflammation; Crohn Disease; Plaque psoriasis
Details
  • Product Inquiry
  • Marketed Drug Information
  • Clinical Drug Information
Share to:

Join UsLegalSite MapPrivacy PolicyTerms and Conditions
Website Feedback
Contact Us

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

이메일
order.kr@acrobiosystems.com

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호